Metraipolis › archive › dc_efd1c803be64

Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial — Europe PMC PMID:41514054

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41514054
DOI
10.1038/s43018-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-06T23:02:17.107Z
SHA-256 of the archived text
0e2075ad622a643deed6d823c9cb75bfc21c957adcd305d66ecb163feb9a845f
Stable URL of this page
https://metraipolis.com/documento/dc_efd1c803be64

How to cite

Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial — Europe PMC PMID:41514054 — Europe PMC (en), https://europepmc.org/article/MED/41514054 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_efd1c803be64 (Metraipolis archive dc_efd1c803be64, sha256 0e2075ad622a643deed6d823c9cb75bfc21c957adcd305d66ecb163feb9a845f)
BibTeX
@misc{dcefd1c803be64,
  title = {Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial — Europe PMC PMID:41514054},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41514054},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_efd1c803be64; sha256 0e2075ad622a643deed6d823c9cb75bfc21c957adcd305d66ecb163feb9a845f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514054. Agents can read the archived copy with the MCP tool read_document.